The competitive implications of certifications: The effects of scientific and regulatory certifications on entries into new technical fields

Academy of Management Journal

Volumn 56, Issue 2, 2013, Pages 597-627

  Polidoro, Francisco ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84879648160     PISSN: 00014273     EISSN: None     Source Type: Journal    
DOI: 10.5465/amj.2011.0459     Document Type: Article

References (95)

1. Afuah, A. 2002. Mapping technological capabilities into product markets and competitive advantage: The case of cholesterol drugs. Strategic Management Journal, 23: 171-179.
2. Agarwal, R., Ganco, M., & Ziedonis, R. 2009. Reputations for toughness in patent enforcement: Implications for knowledge spillovers via inventor mobility. Strategic Management Journal, 30: 1349-1374.
3. Akerlof, G. 1970. The market for "lemons": Quality uncertainty and the market mechanism. Quarterly Journal of Economics, 84: 488-500.
4. Alchilladelis, B. 1999. Innovation in the pharmaceutical industry. In R. Landau, B. Achilladelis, & A. Scriabine (Eds.), Pharmaceutical innovation: Revolutionizing human health: 1-147. Philadelphia: Chemical Heritage Press.
5. Anand, J., & Delios, A. 2002. Absolute and relative resources as determinants of international acquisitions. Strategic Management Journal, 23: 119-134.
6. Azoulay, P. 2002. Do pharmaceutical sales respond to scientific evidence? Journal of Economics and Management Strategy, 11: 551-594.
7. Barney, J. B. 1986. Strategic factor markets: Expectations, luck, and business strategy. Management Science, 32: 1231-1241.
8. Baum, J. A. C. 1996. Organizational ecology. In S. R. Clegg, C. Hardy, & W. R. Nord (Eds.), Handbook of organization studies: 77-114. Thousand Oaks, CA: Sage.
9. Beatty, R., & Ritter, J. 1986vestment banking, reputation, and the underpricing of initial public offerings. Journal of Financial Economics, 15: 213-232.
10. Bodewitz, H., Buurma, H., & DeVries, G. H. 1987. Regulatory science and the social management of trust in medicine. In W. E. Bijker, T. P. Hughes, & T. J. Pinch (Eds.), The social construction of technological systems: 243-259. Cambridge, MA: MIT Press.
11. Cameron, A. D., Gelbach, J. B., & Miller, D. L. 2011. Robust inference with multiway clustering. Journal of Business and Economic Statistics, 29: 238-249.
12. Ceccagnoli, M., Graham, S. J. H., Higgins, M. J., & Lee, J. 2010. Productivity and the role of complementary assets in firms' demand for technology innovations
13. Choi, J. P. 1991. Dynamic R&D competition under "hazard rate" uncertainty. RAND Journal of Economics, 22: 596-610.
14. Christensen, C. M. 1997. The innovator's dilemma. Boston: Harvard Business School Press.
15. Courvoisier, D. S., Combescure, C., Agoritsas, T., Gayet- Ageron, A., & Perneger, T. V. 2011. Performance of logistic regression modeling: Beyond the number of events per variable, the role of data structure. Journal of Clinical Epidemiology, 64: 993-1000.
16. Couzin, J. 2005. The brains behind blockbusters. Science, 309: 728-730.
17. D'Aveni, R. 1994. Hypercompetition. New York: Free Press.
18. Danzon, P. M. 2000. The pharmaceutical industry. In B. Bouckaert & G. D. Geest (Eds.), The encyclopedia of law and economics: 1055-1091. Cheltenham, UK: Elgar.
19. Dasgupta, P. 1988. Patents, priority and imitation, or the economics of races and waiting games. Economic Journal, 98: 66-80.
20. DiMaggio, P. J., & Powell, W. W. 1983. The iron cage revisited: Institutional isomorphism and collective rationality in organizational fields. American Sociological Review, 48: 147-160.
21. DiMasi, J. A., & Paquette, C. 2004. The economics of follow-on drug research and development. Pharmacoeconomics, 22 (Suppl. 2): 1-14.
22. Dosi, G. 1982. Technological paradigms and technological trajectories. Research Policy, 11: 147-162.
23. Dranove, D., & Meltzer, D. 1994. Do important drugs reach the market sooner? RAND Journal of Economics, 25: 402-423.
24. Eisenhardt, K. M. 1989. Making fast decisions in highvelocity environments. Academy of Management Journal, 32: 543-576.
25. Fleming, L., Mingo, S., & Chen, D. 2007. Collaborative brokerage, generative creativity, and creative success. Administrative Science Quarterly, 52: 443-475.
26. Fleming, L., & Sorenson, O. 2004. Science as a map in technological search. Strategic Management Journal Special Issue, 25: 909-928.
27. Flowers, C. R., & Melmon, K. L. 1999. Clinical champions as critical determinants of drug development R.Landau, B. Achilladelis, & A. Scriabine (Eds.), Pharmaceutical innovation: Revolutionizing human health: 331-372. Philadelphia: Chemical Heritage Press.
28. Fudenberg, D., Gilbert, R., Stiglitz, J., & Tirole, J. 1983. Preemption, leapfrogging, and competition in patent races. European Economic Review, 22: 3-31.
29. GAO. 2002. Effect of user fees on drug approval times, withdrawals, and other agency activities (GAO-02- 958). Washington, DC: Unites States Government Accountability Office.
30. GAO. 2010. Nanotechnology: Nanomaterials are widely used in commerce, but EPA faces challenges in regulating risk (GAO-10-549). Washington, DC: United States Government Accountability Office.
31. Garud, R., & Rappa, M. A. 1994. A socio-cognitive model of technology evolution: The case of cochlear implants. Organization Science, 5: 344-362.
32. Gilbert, R. J., & Newbery, D. M. G. 1982. Preemptive patenting and the persistence of monopoly. American Economic Review, 72: 514-526.
33. Gittelman, M., & Kogut, B. 2003. Does good science lead to valuable knowledge? Biotechnology firms and the evolutionary logic of citation patterns. Management Science, 49: 366-382.
34. Godin, B. 1996. Research and the practice of publication in industries. Research Policy, 25: 587-606.
35. Granovetter, M. 1985. Economic action and social structure: The problem of embeddedness. American Journal of Sociology, 91: 481-510.
36. Greene, W. H. 2003. Econometric analysis. Upper Saddle River, NJ: Prentice Hall.
37. Griliches, Z. 1990. Patent statistics as economic indicators: A survey. Journal of Economic Literature, 28: 1661-1707.
38. Hamilton, B. H., & Nickerson, J. A. 2003. Correcting for endogeneity in strategic management research. Strategic Organization, 1: 51-78.
39. Hannan, M. T., & Freeman, J. 1977. The population ecology of organizations. American Journal of Sociology, 82: 929-964.
40. Heckman, J. J. 1979. Sample selection bias as a specification error. Econometrica, 47: 153-161.
41. Henderson, R., & Clark, K. 1990. Architectural innovation: The reconfiguration of existing product technologies and the failure of established firms. Administrative Science Quarterly, 35: 9-30.
42. Henderson, R., & Cockburn, I. 1994. Measuring competence? Exploring firm effects in pharmaceutical research. Strategic Management Journal, 15: 63-84.
43. Higgins, M. C., & Gulati, R. 2003. Getting off to a good start: The effects of upper echelon affiliations on underwriter prestige. Organization Science, 14: 244-263.
44. Hilts, P. J. 2003. Protecting America's health: The FDA, business and one hundred years of regulation. Chapel Hill: University of North Carolina Press.
45. Hoetker, G. 2007. The use of logit and probit models in strategic management research: Critical issues. Strategic Management Journal, 28: 331-343.
46. Hosmer, D. W., & Lemeshow, S. 1999. Applied survival analysis: Regression modeling of time to event data. New York: Wiley.
47. King, A. A., Lenox, M. J., & Terlaak, A. 2005. The strategic use of decentralized institutions: Exploring certification with the ISO 14001 management standard. Academy of Management Journal, 48: 1091-1106.
48. King, A. A., & Tucci, C. L. 2002
49. King, G., & Zeng, L. 2001. Logistic regression in rare events data. Political Analysis, 9(2): 137-163.
50. Kleinbaum, D. G., Kupper, L. L., & Muller, K. E. 1988. Applied regression analysis and other multivariate methods. Boston: PWS-Kent.
51. Klepper, S., & Simons, D. 2000. Dominance by birthright: Entry of prior radio producers and competitive ramification in the U.S. television receiver industry. Strategic Management Journal, 21: 997-1016.
52. Kotha, R., Zheng, Y., & George, G. 2011. Entry into new niches: The effects of firm age and the expansion of technological capabilities on innovative output and impact. Strategic Management Journal, 32: 1011-1024.
53. Kuhn, T. 1996 [1962]. The structure of scientific revolutions. Chicago: Chicago University Press.
54. Lieberman, M. B., & Montgomery, D. B. 1988. First-mover advantages. Strategic Management Journal, 9: 41-58.
55. Lippman, S. A., & McCardle, K. F. 1987. Dropout behavior in R&D races with learning. RAND Journal of Economics, 18: 287-295.
56. Martin, X., & Mitchell, W. 1998. The influence of local search and performance heuristics on new design introduction in a new product market. Research Policy, 26: 753-771.
57. McGrath, R. 1997. A real options logic for initiating technology positioning investments. Academy of Management Review, 22: 974-996.
58. Merton, R. K. 1968. The Matthew effect in science. Science, 159: 56-63.
59. Merton, R. K. 1973. The sociology of science: Theoretical and empirical investigations. Chicago: University of Chicago Press.
60. Meyer, J. W., & Rowan, B. 1977
61. Mitchell, W. 1989. Whether and when? Probability and timing of incumbents' entry into emerging industrial subfields. Administrative Science Quarterly, 34: 208-230.
62. Mowery, D. C., Oxley, J. E., & Silverman, B. S. 1998. Strategic alliances and interfirm knowledge transfer. Strategic Management Journal, 17(winter special issue): 77-91.
63. Nelson, R. R. 1991. Why do firms differ, and how does it matter? Strategic Management Journal, 12: 61-74.
64. Nelson, R. R., & Winter, S. G. 1982. An evolutionary theory of economic change. Cambridge, MA: Belknap.
65. Noll, R. G. 1989. Economic perspectives on the politics of regulation. In R. Schmalensee & R. D. Willig (Eds.), Handbook of industrial organization: 1253-1287. Amsterdam: Elsevier Science.
66. Olson, M. K. 1999. Agency rulemaking, political influences, regulation, and industry compliance. Journal of Law, Economics & Organization, 15: 573-601.
67. Penner-Hahn, P., & Shaver, J. M. 2005. Does international research and development increase patent output? An analysis of Japanese pharmaceutical firms. Strategic Management Journal, 26: 121-140.
68. Podolny, J. M., & Stuart, T. E. 1995. A role-based ecology of technological change. American Journal of Sociology, 100: 1224-1260.
69. Polanyi, K. 1944. The great transformation. Boston: Beacon Press.
70. Pollock, T. G., & Gulati, R. 2007. Standing out from the crowd: The visibility-enhancing effects of IPOrelated signals on alliance formation by entrepreneurial firms. Strategic Organization, 5: 339-372.
71. Rao, H. 1994. The social construction of reputation: Certification contests, legitimation, and the survival of organizations in the American automobile industry: 1895-1912. Strategic Management Journal, 15: 29-44.
72. Reinganum, J. F. 1983. Uncertain innovation and the persistence of monopoly. American Economic Review, 73: 741-748.
73. Reuben, B. G., & Wittcoff, H. A. 1989. Pharmaceutical chemicals in perspective. New York: Wiley.
74. Rindova, V. P., Williamson, I. O., Petkova, A. P., & Sever, J. M. 2005. Being good or being known: An empirical examination of the dimensions, antecedents, and consequences of organizational reputation. Academy of Management Journal, 48: 1033-1049.
75. Rosenberg, N. 1976. Perspectives on technology. Cambridge, UK: Cambridge University Press.
76. Scriabine, A. 1999. Discovery and development of major drugs currently in use. In R. Landau, B. Achilladelis, & A. Scriabine (Eds.), Pharmaceutical innovation: Revolutionizing human health: 148-270. Philadelphia: Chemical Heritage Press.
77. Sharma, A., & Lacey, N. 2004. Linking product development outcomes to market valuation of the firm: The case of the U.S. pharmaceutical industry. Journal of Product Innovation Management, 21: 297-308.
78. Sine, W. D., David, R. J., & Mitsuhashi, H. 2007. From plan to plant: Effects of certification on operational start-up in the emergent independent power sector. Organization Science, 18: 578-594.
79. Skinner, D. J. 1994. Why firms voluntarily disclose bad news. Journal of Accounting Research, 32: 38-60.
80. Spence, A. M. 1974. Market signaling. Cambridge, MA: Harvard University Press.
81. Stuart, T. E., Hoang, H., & Hybels, R. C. 1999
82. Teece, D. 1986. Profiting from technological innovation: Implications for integration, collaboration, licensing, and public policy. Research Policy, 15: 285-305.
83. Thompson, J. D. 1967. Organizations in action: Social science bases of administrative theory. New York: McGraw Hill.
84. Tolbert, P. S., & Zucker, L. G. 1983
85. Trajtenberg, M. 1990. A penny for your quotes: Patent citations and the value of innovations. RAND Journal of Economics, 21: 172-187.
86. Travis, J. 2005. Saving the mind faces high hurdles. Science, 309: 731-734.
87. Tripsas, M. 1997. Unraveling the process of creative destruction: Complementary assets and firm survival in the typesetter industry. Strategic Management Journal, 18: 119-142.
88. Tushman, M. L., & Anderson, P. 1986. Technological discontinuities and organizational environments. Administrative Science Quarterly, 31: 439-465.
89. Tushman, M. L., & Rosenkopf, L. 1992. Organizational determinants of technological change: Toward a sociology of technological evolution. In B. M. Staw & L. L. Cummings (Eds.), Research in organizational behavior, vol. 14: 311-347. Greenwich, CT: JAI.
90. Weigelt, K., & Camerer, C. 1988. Reputation and corporate strategy: A review of recent theory and applications. Strategic Management Journal, 9: 443-454.
91. Westphal, J. D., Gulati, R., & Shortell, S. M. 1997. Customization or conformity? An institutional and network perspective on the content and consequences of TQM adoption. Administrative Science Quarterly, 42: 366-394.
92. Westphal, J. D., & Zajac, E. J. 1994. Substance and symbolism in CEOs' long-term incentive plans. Administrative Science Quarterly, 39: 367-390.
93. White, H. C. 1981. Where do markets come from? American Journal of Sociology, 87: 517-547.
94. Wooldridge, J. M. 2002. Econometric analysis of cross section and panel data. Cambridge, MA: MIT Press.
95. Ziman, J. M. 1968. Public knowledge: An essay concerning the social dimension of science. Cambridge, MA: MIT Press.